Effect of screening mammography on breast cancer survival in comparison to other detection methods: a retrospective cohort study
- PMID: 19493274
- PMCID: PMC11158809
- DOI: 10.1111/j.1349-7006.2009.01212.x
Effect of screening mammography on breast cancer survival in comparison to other detection methods: a retrospective cohort study
Abstract
The effectiveness of screening mammography (SMG) on mortality has been established in randomized controlled trials in Western countries, but not in Japan. This study evaluated the effectiveness by comparing the survival based on detection methods. The survivals were estimated by the Kaplan-Meier method. Breast cancer patients diagnosed from 1 January 1989 to 31 December 2000 were determined using the Miyagi Prefectural Cancer Registry and follow-up was performed from the date of the diagnosis until the date of death or the end of follow-up, 31 December 2005. The hazard ratios (HR) and 95% confidence interval (CI) of breast cancer death based on the detection methods were estimated by the Cox proportional-hazard regression model. The mean age of the 7513 patients was 55.7 years (range, 15.0-99.3). The 5-year survival associated with the SMG group, the clinical breast examination (CBE) group, and the self-detection group was 98.3%, 94.3%, and 84.8%, respectively. The HR (95% CI) of deaths from breast cancer was 2.50 (1.10-5.69) for patients in the CBE group and 6.57 (2.94-14.64) for the self-detection group in comparison to the SMG group. In women aged 50-59, the HRs were 1.64 (0.58-4.62) among the CBE group and 3.74 (1.39-10.03) among the self-detection group, and the HRs for the CBE and self-detection groups in women aged 60-69 were 2.96 (0.68-12.83) and 9.51 (2.36-38.26), respectively. After adjusting for stage, the HRs dropped remarkably. Screening mammography may be more effective in the elderly group and be able to reduce the mortality of breast cancer in Japan.
Figures

Similar articles
-
Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.Breast Cancer. 2014 Sep;21(5):542-9. doi: 10.1007/s12282-012-0434-2. Epub 2012 Dec 14. Breast Cancer. 2014. PMID: 23239243
-
Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.CMAJ. 1992 Nov 15;147(10):1477-88. CMAJ. 1992. PMID: 1423088 Free PMC article. Clinical Trial.
-
Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.CMAJ. 1992 Nov 15;147(10):1459-76. CMAJ. 1992. PMID: 1423087 Free PMC article. Clinical Trial.
-
Breast cancer mortality in relation to clinical breast examination and breast self-examination.Breast J. 2003 May-Jun;9 Suppl 2:S86-9. doi: 10.1046/j.1524-4741.9.s2.9.x. Breast J. 2003. PMID: 12713502 Review.
-
[Characteristics of screening-detected breast cancer and trends in its therapy].Gan To Kagaku Ryoho. 1998 Aug;25(10):1493-8. Gan To Kagaku Ryoho. 1998. PMID: 9725039 Review. Japanese.
Cited by
-
Retrospective analysis of mammographic findings for Japanese women: a potential predictor for breast malignancies.Cancer Sci. 2012 Mar;103(3):472-6. doi: 10.1111/j.1349-7006.2011.02169.x. Epub 2011 Dec 28. Cancer Sci. 2012. PMID: 22129163 Free PMC article.
-
Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3153-3160. doi: 10.31557/APJCP.2019.20.10.3153. Asian Pac J Cancer Prev. 2019. PMID: 31653167 Free PMC article.
-
Lasting Effects of the Breast and Cervical Cancer Early Detection Program on Breast Cancer Detection and Outcomes, Ohio, 2000-2009.Prev Chronic Dis. 2015 Jul 23;12:E116. doi: 10.5888/pcd12.140491. Prev Chronic Dis. 2015. PMID: 26203814 Free PMC article.
-
Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality.NPJ Breast Cancer. 2021 Jun 28;7(1):83. doi: 10.1038/s41523-021-00295-9. NPJ Breast Cancer. 2021. PMID: 34183679 Free PMC article.
References
-
- Berry DA, Cronin KA, Plevritis SK et al . Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784–92. - PubMed
-
- Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population‐based cancer registries. Jpn J Clin Oncol 2008; 38: 641–8. - PubMed
-
- Ministry of Health, Labour and Welfare of Japan . Health Statistics in Japan, 2007. Health Statistics Office, Statistics and Information Department. Tokyo: Ministry of Health, Labour and Welfare, 2007; 35.
-
- Armesto SG, Lapetra ML, Wei L, Kelley E, the Members of the HCQI Expert Group . Health Care Quality Indicators Project 2006 Data Collection Update Report, 29th edn. Paris: OECD, 2007; 35.
-
- Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39: 2772–82. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical